| Literature DB >> 34519539 |
Julia Niessl1, Takuya Sekine1, Joshua Lange1, Viktoria Konya1, Marianne Forkel1, Jovana Maric1, Anna Rao1, Luca Mazzurana1, Efthymia Kokkinou1, Whitney Weigel1, Sian Llewellyn-Lacey2, Emma B Hodcroft3,4, Annika C Karlsson5, Johan Fehrm6,7, Joar Sundman6,7, David A Price2,8, Jenny Mjösberg1, Danielle Friberg9, Marcus Buggert1.
Abstract
Cross-reactive CD4+ T cells that recognize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more commonly detected in the peripheral blood of unexposed individuals compared with SARS-CoV-2–reactive CD8+ T cells. However, large numbers of memory CD8+ T cells reside in tissues, feasibly harboring localized SARS-CoV-2–specific immune responses. To test this idea, we performed a comprehensive functional and phenotypic analysis of virus-specific T cells in tonsils, a major lymphoid tissue site in the upper respiratory tract, and matched peripheral blood samples obtained from children and adults before the emergence of COVID-19 (coronavirus disease 2019). We found that SARS-CoV-2–specific memory CD4+ T cells could be found at similar frequencies in the tonsils and peripheral blood in unexposed individuals, whereas functional SARS-CoV-2–specific memory CD8+ T cells were almost only detectable in the tonsils. Tonsillar SARS-CoV-2–specific memory CD8+ T cells displayed a follicular homing and tissue-resident memory phenotype, similar to tonsillar Epstein-Barr virus–specific memory CD8+ T cells, but were functionally less potent than other virus-specific memory CD8+ T cell responses. The presence of preexisting tissue-resident memory CD8+ T cells in unexposed individuals could potentially enable rapid sentinel immune responses against SARS-CoV-2.Entities:
Mesh:
Year: 2021 PMID: 34519539 DOI: 10.1126/sciimmunol.abk0894
Source DB: PubMed Journal: Sci Immunol ISSN: 2470-9468